| Mrs Guiselly Astrid Erazo-romero, | |
|
4180 W 11 Mile Rd, Novi, MI 48375-1818 | |
| (240) 469-9972 | |
| Not Available |
| Full Name | Mrs Guiselly Astrid Erazo-romero |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 4180 W 11 Mile Rd, Novi, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528551223 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | R217253 (Maryland) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | R217153 (Maryland) | Primary |
| Entity Name | Malik & Qadir Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003979717 PECOS PAC ID: 8224221536 Enrollment ID: O20101019001274 |
News Archive
Eric J. Hall, president and CEO of the Alzheimer's Foundation of America, today noted the centennial birthday of President Ronald Reagan on February 6 by issuing a statement that acknowledged the former President's contribution to Alzheimer's awareness.
Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.
Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.
Researchers have been identifying and modifying known phages to fight against infectious bacteria.
MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it's going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.
› Verified 1 days ago
| Entity Name | Allegeny Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821370644 PECOS PAC ID: 2860631959 Enrollment ID: O20130621000097 |
News Archive
Eric J. Hall, president and CEO of the Alzheimer's Foundation of America, today noted the centennial birthday of President Ronald Reagan on February 6 by issuing a statement that acknowledged the former President's contribution to Alzheimer's awareness.
Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.
Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.
Researchers have been identifying and modifying known phages to fight against infectious bacteria.
MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it's going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.
› Verified 1 days ago
| Entity Name | Openloop Healthcare Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245820661 PECOS PAC ID: 2668871898 Enrollment ID: O20210915002780 |
News Archive
Eric J. Hall, president and CEO of the Alzheimer's Foundation of America, today noted the centennial birthday of President Ronald Reagan on February 6 by issuing a statement that acknowledged the former President's contribution to Alzheimer's awareness.
Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.
Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.
Researchers have been identifying and modifying known phages to fight against infectious bacteria.
MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it's going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.
› Verified 1 days ago
| Entity Name | Tapestry Telehealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992215446 PECOS PAC ID: 4789942335 Enrollment ID: O20220705000390 |
News Archive
Eric J. Hall, president and CEO of the Alzheimer's Foundation of America, today noted the centennial birthday of President Ronald Reagan on February 6 by issuing a statement that acknowledged the former President's contribution to Alzheimer's awareness.
Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.
Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.
Researchers have been identifying and modifying known phages to fight against infectious bacteria.
MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it's going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.
› Verified 1 days ago
| Entity Name | Telehealth Solution Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790221299 PECOS PAC ID: 4284902552 Enrollment ID: O20230216000936 |
News Archive
Eric J. Hall, president and CEO of the Alzheimer's Foundation of America, today noted the centennial birthday of President Ronald Reagan on February 6 by issuing a statement that acknowledged the former President's contribution to Alzheimer's awareness.
Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.
Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.
Researchers have been identifying and modifying known phages to fight against infectious bacteria.
MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it's going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Guiselly Astrid Erazo-romero, 17568 Shale Dr, Hagerstown, MD 21740-2044 Ph: (240) 469-9972 | Mrs Guiselly Astrid Erazo-romero, 4180 W 11 Mile Rd, Novi, MI 48375-1818 Ph: (240) 469-9972 |
News Archive
Eric J. Hall, president and CEO of the Alzheimer's Foundation of America, today noted the centennial birthday of President Ronald Reagan on February 6 by issuing a statement that acknowledged the former President's contribution to Alzheimer's awareness.
Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.
Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.
Researchers have been identifying and modifying known phages to fight against infectious bacteria.
MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it's going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.
› Verified 1 days ago